Navigation Links
TriReme Announces Signing of a Master Distribution Agreement in China
Date:3/26/2013

PLEASANTON, Calif. and SINGAPORE, March 26, 2013 /PRNewswire/ -- TriReme Medical, Inc. and its affiliates (TriReme) announced today that it has signed a comprehensive agreement with Weihai Weigao Medical Devices, Ltd for the distribution of its products in the People's Republic of China. Weigao will act as TriReme's master distributor by selling TriReme products directly to hospitals as well as connecting TriReme products into its vast nationwide distribution network. This agreement complements TriReme's strategy of focusing on Asia, the fastest growing market in interventional cardiology.

"Due to many factors including increased affordability, aging population and an increase in the number of state-of-the-art medical facilities, China has become the world's second largest market in terms of the volume of interventional coronary vascular procedures," stated Eitan Konstantino Ph.D, CEO and President of TriReme. "For similar reasons, we expect that the number of peripheral vascular procedures will rise dramatically in the coming years to the point where China becomes the world's largest market in terms of total vascular interventions."

Ms CHU Swee Yeok, CEO and President, EDBI and Bio*One Capital said: "We are confident that TriReme products and technologies will lead to better clinical outcomes for Chinese patients and are thrilled to partner with a distinguished player like Weigao to introduce TriReme products into the world's fastest growing healthcare market. Such a partnership is a great example of how highly innovative companies like TriReme can leverage on Singapore as a base to access vital Asia markets for their growth."

"Weigao remains committed to partnering with healthcare providers across China to provide access to best-in-class technology across a wide range of product categories," explained Mr SUN Feng Wei, General Manager of Weigao Medical Devices, Ltd. "We view TriReme as a top brand and this partnership allows us to bring the highest quality devices to our growing customer base of physicians performing interventional vascular procedures."

About TriReme Medical, Inc.

Based in Singapore and Pleasanton, California, TriReme Medical, Inc. is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease. The company is focused on the US and the emerging Asian markets.

About Weigao

Based in Weihai, China and publicly traded on the Hong Kong Stock exchange (Stock Code: 1066), Weigao manufactures and sells over 100 types of products, including disposable medical consumables, orthopedic materials and tools, medical needles, blood purification consumables, and interventional cardiology devices. It maintains a vast distribution network of 24 regional sales offices, 30 customer service centers, 100 municipal representatives, and 1200 sales representatives. It sells to over 2700 hospitals, 400 blood stations, and over 1500 distribution/trading partners across China.


'/>"/>
SOURCE TriReme Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. TriReme Announces a New Round of Financing Totalling US$18 Million
2. TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter
3. Genalyte Announces CE Mark For Maverick(TM) Detection System And Signs On First European Distributors
4. Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
5. ECRI Institute Announces 2013 Health Devices Achievement Award -- Call for Entries
6. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2012 and to Provide a Business Update
7. Research and Markets Announces The Release of Neuromodulation Market - Forecasts to 2017
8. SARcode Bioscience Announces Acquisition by Shire US Holdings Inc.
9. Creative Edge Nutrition, Inc. Announces the Entrance into the Medical Marijuana Sector
10. arGEN-X Announces Preclinical Development of ARGX-112 for Dermatology
11. United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Research ... "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural Health ... Structural electronics involves electronic and/or electrical ... structures, replacing dumb structures such as vehicle bodies ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
Breaking Medicine News(10 mins):